Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1988-8-4
|
pubmed:abstractText |
The effects of hydralazine on tumor energy metabolism and on some cardiovascular parameters were measured. Tumor energy metabolism was studied in C3Hf/Sed mice with isotransplants of a spontaneous murine fibrosarcoma (FSaII, congruent to 100 mm3 in volume) and 31P-NMR. Cardiovascular parameters were measured in anesthetized C3Hf/Sed mice via intracarotid catheter. Hydralazine doses of 0.25 mg/kg given ip caused an increase of the phosphocreatine to inorganic phosphate ratio (PCr: Pi) in 5 of 6 animals. These doses had minimal effects on mean arterial blood pressure, though there may have been an increased cardiac output due to a decreased afterload. Hydralazine doses greater than or equal to 2.0 mg/kg given ip were associated with a decrease in PCr, nucleotide triphosphate, and pH, and an increase in Pi (P less than .01 for control vs. 10 mg hydralazine/kg). This substantial decrease in high-energy phosphates was associated with a pronounced decrement in mean arterial blood pressure. These findings provide a rational basis for the study in experimental systems of hydralazine-induced enhancement of cell killing by hyperthermia and by agents toxic to hypoxic cells. Further, these results can be taken as a sign that hydralazine should be used with care in patients undergoing radiation treatment.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0027-8874
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
745-50
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3385782-Animals,
pubmed-meshheading:3385782-Blood Pressure,
pubmed-meshheading:3385782-Cardiac Output,
pubmed-meshheading:3385782-Dose-Response Relationship, Drug,
pubmed-meshheading:3385782-Energy Metabolism,
pubmed-meshheading:3385782-Female,
pubmed-meshheading:3385782-Hydralazine,
pubmed-meshheading:3385782-Magnetic Resonance Spectroscopy,
pubmed-meshheading:3385782-Male,
pubmed-meshheading:3385782-Mice,
pubmed-meshheading:3385782-Mice, Inbred C3H,
pubmed-meshheading:3385782-Neoplasms,
pubmed-meshheading:3385782-Phosphates,
pubmed-meshheading:3385782-Phosphocreatine,
pubmed-meshheading:3385782-Vasodilation
|
pubmed:year |
1988
|
pubmed:articleTitle |
Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31P-nuclear magnetic resonance spectroscopy.
|
pubmed:affiliation |
Department of Radiation Medicine, Massachusetts General Hospital, Boston 02114.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|